Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "poison pill."
12 result(s) displayed (13 - 24 of 24)
The toy company is fighting an unsolicited offer from Oaktree Capital. Continue reading
Posted on March 15, 2012 9:15 AM
Shareholders in the gene-sequencing specialist continue to bet on a sweetened offer Continue reading
Posted on February 27, 2012 10:38 AM
In his new book, UCLA law professor and popular blogger Stephen Bainbridge provides a longer historical perspective on one aspect of the choking proliferation of rulemaking. Continue reading
Posted on February 21, 2012 1:24 PM
In his new book, UCLA law professor and popular blogger Stephen Bainbridge provides a longer historical perspective on one aspect of the choking proliferation of rulemaking. Continue reading
Posted on February 21, 2012 1:13 PM
The target's rejection of Roche's $5.4 billion offer prompts hopes of a bump in price. Continue reading
Posted on February 9, 2012 9:55 AM
Roche Holding AG on Friday, Jan. 27, professed itself "disappointed," but not surprised, after Illumina Inc. adopted a poison pill to thwart the Swiss pharmaceutical company's $5.7 billion unwanted approach.Illlumina Thursday said it would give investors who hold its shares... Continue reading
Posted on January 27, 2012 8:56 AM
The gene sequencing specialist aims to fight off a hostile $5.7 billion bid from Roche. Continue reading
Posted on January 26, 2012 1:32 PM
The board of the Canadian gold and copper miner reverses course and pledges to recommend shareholders lift an ill-fated poison pill provision at a May meeting. Continue reading
Posted on January 19, 2012 8:52 AM
Jeffrey Kaplan, BofA's outgoing M&A chief, lays out the landscape for 2011. Continue reading
Posted on March 11, 2011 12:44 PM
Although he didn't like it, Chandler upholds Airgas' takeover defense, then considers the now-venerable tactic. Continue reading
Posted on February 18, 2011 11:28 AM
Deal Economy 2011: Legendary M&A attorney Martin Lipton talks about how the age of the corporate raider inspired him to invent the poison pill. Continue reading
Posted on January 12, 2011 1:22 PM
Movable Type search results powered by Fast Search
Ken deRegt will retire as head of fixed income at Morgan Stanley and be replaced by Michael Heaney and Robert Rooney. For other updates launch today's Movers & shakers slideshow.
Apax Partners offers $1.1 billion for Rue21, the same teenage fashion chain it took public in 2009. More video
